nCino reported earnings on August 26, and the Street has moved quickly to push targets higher — a broad analyst upgrade wave running alongside continued short covering that gives the post-print setup a notably different tone from the cautious pre-earnings positioning covered in the two prior notes.
The analyst response is the clearest signal from the past 24 hours. Firms across the coverage universe raised price targets on Wednesday, with the bulls well represented: Morgan Stanley lifted its Overweight target from $23 to $25, Barclays moved from $22 to $23 while holding Overweight, Piper Sandler assumed with an Overweight and a $25 target, and Keefe, Bruyette & Woods raised to $25 from $24 at Outperform. The consensus mean target has settled around $24.27 — roughly 17% above Tuesday's close of $20.81. The bears remain present but quieter: BTIG reiterated Neutral without attaching a target, and Truist held its Hold rating, lifting only to $20. The overall picture is one of cautious-to-constructive tilting toward constructive, with the Street broadly acknowledging the print without dramatically changing its view on valuation risk.
Short positioning has continued to ease in the days around the earnings event, reinforcing the pre-print pattern. Bears have trimmed exposure by roughly 15% over the past month, bringing short interest to approximately 15.4% of the free float from over 20% in late July. The directional retreat is steady rather than panicked. Borrow conditions remain completely relaxed — availability is running at nearly 320%, meaning the lending pool has more than three shares available for every one currently borrowed. Cost to borrow sits below 0.55%, essentially negligible. The ORTEX short score has eased to 64.4 from a recent high near 66.4, consistent with modest rather than aggressive short unwinding. The setup carries meaningful residual short interest, but no squeeze tension.
Options positioning has backed off its pre-earnings caution. The put/call ratio edged up to 0.33 ahead of the print — about 1.5 standard deviations above its 20-day average of 0.25 — but that reading now reflects the post-event reset rather than fresh directional conviction. The 52-week PCR range runs from 0.03 to 0.59, so the current level is neither extreme. On the institutional side, the most notable recent move is from AQR Capital, which added over 4.6 million shares in the quarter ending June 30, bringing its stake to 6.4% of shares. BlackRock similarly added 3.4 million shares, now holding 8.2%. Those inflows arrived before the August rally, which means both are sitting on gains — a setup that cuts both ways for near-term pressure.
The bull case rests on subscription revenue growth driven by AI and data management investment, expanding international reach, and a valuation that remains lower than many software peers. The EV/EBITDA multiple is running near 12.7x, and the price-to-book has expanded roughly 15% over the past month alongside the stock's 26% rally. Forward EPS momentum ranks in the 77th percentile of nCino's universe — a notable improvement. The bear case centers on competitive pressure, the ongoing Salesforce relationship as a double-edged dependency, and the question of whether the current growth trajectory can sustain the re-rating that August's move has already priced in. The stock has cleared the insider sell prices from early August ($19.20–$19.55), leaving CEO and CFO sales marginally offside on a near-term basis.
What to watch next: how quickly the remaining 15% short position responds to the Street's target upgrades, and whether the institutional buyers who built stakes at lower prices take profits into the post-earnings strength or hold through the next print, now scheduled for December 2.
See the live data behind this article on ORTEX.
Open NCNO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
